https://pubmed.ncbi.nlm.nih.gov/35148883/ transplant

Transplant Proc. 2022 Feb 8;S0041-1345(22)00063-X.
doi: 10.1016/j.transproceed.2022.01.008.Online ahead of print.

Long-Term Outcome of Portal Vein Stenting After Pediatric Living Donor Liver Transplantation

Takehisa Ueno 1, Chiyoshi Toyama 2, Koichi Deguchi 2, Kazunori Masahata 2, Motonari Nomura 2, Miho Watanabe 2, Masafumi Kamiyama 2, Yuko Tazuke 2, Kazuhiko Bessho 3, Hiroomi Okuyama 2

Abstract

Background: Portal vein (PV) stenosis is sometimes seen in pediatric living donor liver transplantation (LDLT). PV stents have been attempted in adults with persistent stenosis. However, long-term usefulness of PV stenting is unknown because stents do not expand with growth. We investigated the effect and long-term outcome of PV stenting for stenosis after pediatric LDLT.
Methods: We included patients aged <18 years who underwent LDLT from 1998 to 2020 and who underwent PV stenting for stenosis. We assessed age at procedure, stent complications, and long-term outcomes.

Results: Five patients underwent PV stent placement. The median age at LDLT was 10 years (range, 0.8-18.1 years). The median interval between LDLT and stent placement was 25 months. The median age at stent placement was 16 years (range, 3-20 years). The median body weight was 38 kg (range, 13-63 kg). The median stent diameter was 8 mm. The median observation period after stent placement was 8 years. On average, body weight increased 1.6 times. One complication associated with stent placement was PV thrombosis, which resulted in stent failure, but we observed no portal hypertension. In the other 4 patients, the stent has remained functioning, and there was no clinical evidence of portal hypertension.

Conclusions: PV stents are effective for intractable PV stenosis in children. PV stents were successfully placed in children as young as 3 years old and weighing 13 kg. Our data suggests that a stent placed in young children does not cause portal hypertension as patients grow.